TARGETING MICRORNA FOR CANCER TREATMENT
- 专利权人:
- Rhode Island Hospital
- 发明人:
- Richard Terek,Qian Chen,Xiaojuan Sun
- 申请号：
- US16082222
- 公开号：
- US20200289542A1
- 申请日:
- 2017.03.06
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- This invention is directed to, inter alia, compositions and methods for restoring normal microRNA (miR) expression in chondrosarcoma cells as well as methods for treating and diagnosing chondrosarcoma in individuals in need thereof.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- FLT3 DIRECTED CAR CELLS FOR IMMUNOTHERAPY
- METHODS OF DIAGNOSIS AND THERAPEUTIC TARGETING OF CLINICALLY INTRACTABLE MALIGNANT TUMORS
- PYRIDO[2,3-D] PYRIMIDIN-7-ONE COMPOUNDS AS INHIBITORS OF PI3K-ALPHA FOR THE TREATMENT OF CANCER
- FLT3 directed car cells for immunotherapy
- TARGETING THE M2-TUMOR ASSOCIATED MACROPHAGE FOR CANCER THERAPY
